CSL reported $47.41B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 36M 20M Jun/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Cara Therapeutics USD 366M 338M Sep/2025
CSL USD 55.89B 20.42B Dec/2025
Curis USD 3M 10M Jun/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Immunic USD 64M 23M Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026